These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
553 related items for PubMed ID: 12190680
1. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Kapiteijn E, Putter H, van de Velde CJ, Cooperative investigators of the Dutch ColoRectal Cancer Group. Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680 [Abstract] [Full Text] [Related]
3. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Rutten H, den Dulk M, Lemmens V, Nieuwenhuijzen G, Krijnen P, Jansen-Landheer M, van de Poll Franse L, Coebergh JW, Martijn H, Marijnen C, van de Velde C. Eur J Cancer; 2007 Oct; 43(15):2295-300. PubMed ID: 17709242 [Abstract] [Full Text] [Related]
4. Blood loss and transfusion after total mesorectal excision and conventional rectal cancer surgery. Mynster T, Nielsen HJ, Harling H, Bülow S, Danish TME-group, RANX05-group. Colorectal Dis; 2004 Nov; 6(6):452-7. PubMed ID: 15521935 [Abstract] [Full Text] [Related]
7. Results after change of treatment policy for rectal cancer--report from a single hospital in China. Wu AW, Gu J, Wang J, Ye SW, An Q, Yao YF, Zhan TC. Eur J Surg Oncol; 2007 Aug; 33(6):718-23. PubMed ID: 17240113 [Abstract] [Full Text] [Related]
8. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Maurer CA, Z'Graggen K, Renzulli P, Schilling MK, Netzer P, Büchler MW. Br J Surg; 2001 Nov; 88(11):1501-5. PubMed ID: 11683749 [Abstract] [Full Text] [Related]
9. Recurrence and survival after mesorectal excision for rectal cancer. Bülow S, Christensen IJ, Harling H, Kronborg O, Fenger C, Nielsen HJ, Danish TME Study Group, RANX05 Colorectal Cancer Study Group. Br J Surg; 2003 Aug; 90(8):974-80. PubMed ID: 12905551 [Abstract] [Full Text] [Related]
10. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T. Br J Surg; 2002 Aug; 89(8):1008-13. PubMed ID: 12153626 [Abstract] [Full Text] [Related]
11. The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: long-term results. Maurer CA, Renzulli P, Kull C, Käser SA, Mazzucchelli L, Ulrich A, Büchler MW. Ann Surg Oncol; 2011 Jul; 18(7):1899-906. PubMed ID: 21298350 [Abstract] [Full Text] [Related]
12. Surgical outcomes after total mesorectal excision for rectal cancer. Chiappa A, Biffi R, Bertani E, Zbar AP, Pace U, Crotti C, Biella F, Viale G, Orecchia R, Pruneri G, Poldi D, Andreoni B. J Surg Oncol; 2006 Sep 01; 94(3):182-93; discussion 181. PubMed ID: 16900534 [Abstract] [Full Text] [Related]
16. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B. Br J Surg; 2005 Feb 01; 92(2):225-9. PubMed ID: 15609382 [Abstract] [Full Text] [Related]
18. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. De Graaf EJ, Doornebosch PG, Tollenaar RA, Meershoek-Klein Kranenbarg E, de Boer AC, Bekkering FC, van de Velde CJ. Eur J Surg Oncol; 2009 Dec 01; 35(12):1280-5. PubMed ID: 19487099 [Abstract] [Full Text] [Related]